KEX Stock Recent News

NEW YORK, Feb. 19, 2025 (GLOBE NEWSWIRE) -- The law firm of Kirby McInerney LLP is investigating potential claims against Septerna, Inc. (“Septerna” or the “Company”) (NASDAQ:SEPN). The investigation concerns whether Septerna and/or certain of its officers have violated the federal securities laws and/or engaged in other unlawful business practices.

NEW YORK, Feb. 18, 2025 (GLOBE NEWSWIRE) -- The law firm of Kirby McInerney LLP is investigating potential claims against Everus Construction Group, Inc. (“Everus” or the “Company”) (NYSE:ECG). The investigation concerns whether Everus and/or certain of its officers have violated the federal securities laws and/or engaged in other unlawful business practices.

NEW YORK--(BUSINESS WIRE)---- $VG #CLASSACTIONLAWSUIT--The law firm of Kirby McInerney LLP announces that a class action lawsuit has been filed in the U.S. District Court for the Southern District of New York on behalf of those who acquired Venture Global, Inc. (“Venture” or the “Company”) (NYSE:VG): common stock pursuant and/or traceable to the registration statement and prospectus (collectively, the “Registration Statement”) issued in connection with the Company's January 2025 initial public offering (“IPO”). Investors.

SAN CARLOS, Calif., Feb. 10, 2025 (GLOBE NEWSWIRE) -- Iovance Biotherapeutics, Inc. (NASDAQ: IOVA), a commercial biotechnology company focused on innovating, developing, and delivering novel polyclonal tumor infiltrating lymphocyte (TIL) therapies for patients with cancer, today announced that Dan Kirby will join the Company's executive leadership team in the newly created role of Chief Commercial Officer, effective today.

KEX's fourth-quarter 2024 earnings and revenues increase year over year.

Kirby Corporation (NYSE:KEX ) Q4 2024 Earnings Conference Call January 30, 2025 8:30 AM ET Company Participants Kurt Niemietz - VP, IR & Treasurer David Grzebinski - CEO Raj Kumar - CFO Christian O'Neil - President & COO Conference Call Participants Reed Seay - Stephens Benjamin Nolan - Stifel Adam Roszkowski - Bank of America Sherif Elmaghrabi - BTIG Greg Wasikowski - Webber Research Operator Good morning, and welcome to the Kirby Corporation 2024 Fourth Quarter Earnings Conference Call. All participants will be in a listen-only mode.

NEW YORK, Jan. 30, 2025 (GLOBE NEWSWIRE) -- The law firm of Kirby McInerney LLP notifies investors of the approaching February 7, 2025, deadline to seek the role of lead plaintiff in a federal securities class action filed on behalf of those who acquired Marqeta, Inc. (“Marqeta” or the “Company”) (NASDAQ:MQ) securities between May 7, 2024, through November 4, 2024 (“the Class Period”).

While the top- and bottom-line numbers for Kirby (KEX) give a sense of how the business performed in the quarter ended December 2024, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.

Kirby (KEX) came out with quarterly earnings of $1.29 per share, beating the Zacks Consensus Estimate of $1.27 per share. This compares to earnings of $1.04 per share a year ago.

NEW YORK, Jan. 29, 2025 (GLOBE NEWSWIRE) -- The law firm of Kirby McInerney LLP is investigating potential claims against Triumph Financial, Inc. (“Triumph” or the “Company”) (NASDAQ:TFIN). The investigation concerns whether Triumph and/or certain of its officers have violated the federal securities laws and/or engaged in other unlawful business practices.